Xcout Intel
Aptis
Aptis Medical specializes in the development of the Aptis DRUJ prosthesis, which is designed to replace the distal radioulnar joint to alleviate pain and weakness.
Subscribe to see Aptis’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Aptis at a glance
Aptis is a networking company headquartered in United States. Its most recent funding round, Series B, raised $3.8M in January 2025. Xcout tracks 1 named person at Aptis, including Dr. Scheker (Founder).
Aptis leadership
- Dr. SchekerFounder
Aptis funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $3.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Aptis competitors
A few of Aptis's closest competitors — see the full list of competitors and alternatives →
Loci Orthopaedics is a medical device company that develops orthopaedic technologies for the extremities space. It primarily focuses on creating innovative implants, such as the InDx implant, for the treatment of thumb base arthritis.
Catalyst OrthoScience Inc. is a medical device company focused on designing and developing precision shoulder replacement solutions for the upper extremity orthopedics market.
Optimotion Implants is a medical device company that designs and manufactures total knee replacement implants and associated surgical instrumentation. Their flagship OI Blue Total Knee System is specifically designed for younger, active patients using a minimally invasive lateral approach suitable for outpatient surgery centers.
Accufix Holdings, Inc. develops and provides the Accu-Joint implant system, an FDA-approved surgical treatment for metatarsophalangeal (MTP) joint disorders such as arthritis. The medical device and associated instruments are designed for surgeons to treat patients by resurfacing the joint, preserving natural bone, and restoring motion rather than performing joint fusion.
Reselute Medical develops therapeutic implant technologies for fracture management, specifically targeting orthopedic-related infections. Its primary product, the investigational Reselution Tibial Intramedullary Fixation System, combines structural bone fixation with sustained local antibiotic delivery in a single procedure for patients with severe fractures.
Arthrotak, LLC develops medical technology for orthopedic surgery, specifically offering a sutureless tendon-to-bone fixation device intended for procedures like biceps tenodesis. The company serves surgeons, ambulatory surgery centers, and hospitals by providing a device that eliminates knot tying, reduces surgical time, and maintains strong fixation strength.
Get Aptis's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Aptis in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access